Real-World Evidence: Why Patients Matter.

“Take 2 tablets and call me in the morning“ We’ve moved, finally, beyond assuming that an off-the-cuff statement like “take 2 and call me in the morning” is sufficient.  But maybe we haven’t moved far enough to ask the important… Continue Reading

Is Your RWE Study In the Weeds? Meet Some Experts Who Can Help.

This year, you can’t swing the proverbial “dead cat” without running into a meeting on Real World Evidence.  This flurry of activity portends good things in that decision-makers are placing greater importance on real world effectiveness data.  Most of us… Continue Reading

Achieving Market Access in India – Are You Hitting the Mark? An Interview with Marksman Healthcare Solutions CEO Dr. Amit Dang

It’s well-accepted that the Indian pharmaceuticals market cannot be ignored.  India will be one of the top 10 sales markets by 2020, fueled by the rapid growth in its population and economy.  Commensurately, India is experiencing expansion within its middle-class… Continue Reading

How are patient decisions formed to stay or drop out of a clinical trial?

Maintaining high levels of patient recruitment, adherence and retention is essential for the successful completion of a clinical trial, yet it remains a significant challenge faced by researchers.  Poor patient adherence and retention can adversely affect a trial by lengthening… Continue Reading